CFZ 300 (Invokana 300 mg)
Generic Name: canagliflozin
Pill with imprint CFZ 300 is White, Capsule-shape and has been identified as Invokana 300 mg. It is supplied by Janssen Pharmaceuticals, Inc..
Invokana is used in the treatment of diabetic kidney disease; diabetes, type 2; cardiovascular risk reduction and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Invokana 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CFZ 300
Invokana
- Generic Name
- canagliflozin
- Imprint
- CFZ 300
- Strength
- 300 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Sglt-2 inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 50458-0141
More about Invokana (canagliflozin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 252 Reviews
- Drug class: SGLT-2 inhibitors
- FDA Alerts (6)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.